CA
NZ
UK
AU
IND
US
• NeoGenomics is up 5.04% intraday at $13.55, holding near session highs in a technically constructive pattern against prior resistance around $13 to $14.
• Definium Therapeutics is trading at $44.15, up 4.79% intraday, peaking near $44.54 as investors digest the landmark Phase 3 MDD readout announced on June 22, 2026.
• Edgewise Therapeutics is trading at $42.39, up 0.21% intraday, effectively unchanged with normal volume and no directional institutional conviction.
• ENDRA Life Sciences is down 6.70% intraday at $5.85, consistent with a pattern of opening strength followed by sharp reversal characteristic of low-float medical device names without fresh catalysts.
• enVVeno Medical is showing a gain of 10.93% at $11.37, but the extremely thin trading volume and possible stale execution mean the print should be treated with significant caution.
• Galectin Therapeutics is trading at $4.05, up 3.32% intraday, in a session of steady accumulation without a sharp spike-and-fade, a constructive intraday pattern.
• Ginkgo Bioworks is trading at $10.38, up 6.68% intraday, carried higher by sector-wide re-rating following Merck KGaA's $11.3 billion acquisition of Bio-Techne.
• TD SYNNEX is a global IT distributor, connecting technology vendors with resellers and solution providers worldwide.
• SOXS, the Direxion Daily Semiconductor Bear 3X ETF, is scheduled for a 1:10 split effective July 15, 2026, per Nasdaq stock-split data.
• SpaceX (SPCX) made its public market debut on the Nasdaq, with Nasdaq market data describing a landmark listing that raised a reported $85.7 billion.
Please wait processing your request...